Skip to main content Accessibility help
  • Print publication year: 2016
  • Online publication date: December 2016

Chapter 20 - CADASIL: a genetic model of arteriolar degeneration, white matter injury, and dementia in later life

Related content

Powered by UNSILO
1.De Leeuw, F. E., de Groot, J. C. and Breteler, M. M. B. (2000) White matter changes: frequency and risk factors. In Pantoni, L., Intzitari, D. and Wallin, A. (eds.) The Matter of White Matter: Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. Utrecht: Academic Pharmaceutical Productions, pp. 1933.
2.Bennett, D. A., Gilley, D. W., Wilson, R. S., Huckman, M. S. and Fox, J. H. (1992) Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer’s disease. J Neurol, 239, 186–90.
3.Bennett, D. A., Gilley, D. W., Lee, S. and Cochran, E. J. (1994) White matter changes: neurobehavioral manifestations of Binswanger’s disease and clinical correlates in Alzheimer’s disease. Dementia, 5, 148–52.
4.Snowdon, D. A. (1997) Aging and Alzheimer’s disease: lessons from the Nun Study. Gerontologist, 37, 150–6.
5.Snowdon, D. A., Greiner, L. H. and Markesbery, W. R. (2000) Linguistic ability in early life and the neuropathology of Alzheimer’s disease and cerebrovascular disease. Findings from the Nun Study. Ann N Y Acad Sci, 903, 34–8.
6.White, L., Petrovitch, H., Hardman, J. et al. (2002) Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci, 977, 923.
7.Schneider, J.A., Arvanitakis, Z., Leurgans, S.E. and Bennett, D. (2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol, 66, 200–8.
8.Alzheimer’s Association (2007) Alzheimer’s Disease Facts and Figures. Chicago, IL: Alzheimer’s Association.
9.Jellinger, K. A. (2002) The pathology of ischemic-vascular dementia: an update. J Neurol Sci, 203–204, 153–7.
10.Amberla, K., Waljas, M., Tuominen, S. et al. (2004) Insidious cognitive decline in CADASIL. Stroke, 35, 1598–602.
11.Charlton, R. A., Morris, R. G., Nitkunan, A. and Markus, H. S. (2006) The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology, 66, 1523–6.
12.Joutel, A., Corpechot, C., Ducros, A. et al. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383, 707–10.
13.Bousser, M. and Tournier-Lasserve, E. (2001) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: from stroke to vessel wall physiology. J Neurol Neurosurg Psychiatry, 70, 285–7.
14.Salloway, S. and Desbiens, S. (2004) CADASIL and other genetic causes of stroke and vascular dementia. In Paul, R., Cohen, R., Ott, B. and Salloway, S. (eds.) Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management. Totowa, NJ: Humana Press, pp. 8798.
15.Joutel, A., Bousser, M. G., Biousse, V. et al. (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet, 5, 40–5.
16.Dong, Y., Hassan, A., Zhang, Z. et al. (2003) Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke, 34, 203–5.
17.Desmond, D. W., Moroney, J. T., Lynch, T. et al. (1999) The natural history of CADASIL: a pooled analysis of previously published cases. Stroke, 30, 1230–3.
18.Viswanathan, A., Gray, F., Bousser, M. G., Baudrimont, M. and Chabriat, H. (2006) Cortical neuronal apoptosis in CADASIL. Stroke, 37, 2690–5.
19.Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E. and Germaine Bousser, M. (2009b) CADASIL. Lancet Neurol, 8, 643–53.
20.Singhal, S., Bevan, S., Barrick, T., Rich, P. and Markus, H. S. (2004) The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain, 127, 2031–8.
21.Dichgans, M., Markus, H., Salloway, S. et al. (2008) Donepezil in patients with subcortical vascular impairment: a randomized, double-blind trial in CADASIL. Lancet Neurol, 7, 310–18.
22.Opherk, C., Peters, N., Herzog, J., Luedtke, R. and Dichgans, M. (2004) Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain, 127: 2533–9.
23.Vahedi, K., Chabriat, H., Levy, C. et al. (2004) Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol, 61, 1237–40.
24.Gunda, B., Hervé, D., Godin, O. et al. (2012) Effects of gender on the phenotype of CADASIL. Stroke, 43, 137–41.
25.Agostoni, E. and Rigamonti, A. (2007) Migraine and cerebrovascular disease. Neurol Sci, 28(Suppl 2), S156–60.
26.Liem, M. K., van der Grond, J., Haan, J. et al. (2007) Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL. Stroke, 38, 923–8.
27.Dichgans, M., Mayer, M., Uttner, I. et al. (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol, 44, 731–9.
28.Thomas, N., Mathews, T. and Loganathan, A. (2002) Cadasil: presenting as a mood disorder. Scott Med J, 47, 36–7.
29.Leyhe, T., Wiendl, H., Buchkremer, G. and Wormstall, H. (2005) CADASIL: underdiagnosed in psychiatric patients? Acta Psychiatr Scand, 111, 392–6; discussion 396–7.
30.Reyes, R., Viswanathan, A., Godin, O. et al. (2009) Apathy: A major symptom in CADASIL. Neurology, 72, 905–10.
31.Chabriat, H., Bousser, M. G. and Pappata, S. (1995) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a positron emission tomography study in two affected family members. Stroke, 26, 1729–30.
32.Lagas, P. A. and Juvonen, V. (2001) Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Nord J Psychiatry, 55, 41–2.
33.Taillia, H., Chabriat, H., Kurtz, A. et al. (1998) Cognitive alterations in non-demented CADASIL patients. Cerebrovasc Dis, 8, 97101.
34.Yousry, T. A., Seelos, K., Mayer, M. et al. (1999) Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Am J Neuroradiol, 20, 91100.
35.Peters, N., Herzog, J., Opherk, C. and Dichgans, M. (2004) A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke, 35, 1603–8.
36.Peters, N., Opherk, C., Danek, A. et al. (2005) The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry, 162, 2078–85.
37.Peters, N., Opherk, C., Zacherle, S. et al. (2004) CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Exp Cell Res, 299, 454–64.
38.Monet-Lepretre, M., Bardot, B., Lemaire, B. et al. (2009) Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain, 132, 1601–12.
39.O’Sullivan, M., Ngo, E., Viswanathan, A. et al. (2009) Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging, 30, 890–7.
40.Gunning-Dixon, F. M. and Raz, N. (2003) Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia, 41, 1929–41.
41.Desmond, D. W. (2004) The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci, 226, 37.
42.Roman, G. C. (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA, 258, 1782–8.
43.Fein, G., Di Sclafani, V., Tanabe, J. et al. (2000) Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology, 55, 1626–35.
44.Patel, K., Correia, S., Foley, J. et al. (2007) Cognitive impairment, hippocampal volume, and white matter integrity in CADASIL. In 35th Annual Meeting of the International Neuropsychological Society, abstract 95.
45.van den Boom, R., Lesnik Oberstein, S. A., Ferrari, M. D., Haan, J. and van Buchem, M. A. (2003) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages: 3rd–6th decades. Radiology, 229, 683–90.
46.Lesnik Oberstein, S. A., van den Boom, R., van Buchem, M. A. et al. (2001) Cerebral microbleeds in CADASIL. Neurology, 57, 1066–70.
47.Dichgans, M. (2002) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: phenotypic and mutational spectrum. J Neurol Sci, 203–204, 7780.
48.Maclean, A. V., Woods, R., Alderson, L. M. et al. (2005) Spontaneous lobar haemorrhage in CADASIL. J Neurol Neurosurg Psychiatry, 76, 456–7.
49.Choi, J. C., Kang, S. Y., Kang, J. H. and Park, J. K. (2006) Intracerebral hemorrhages in CADASIL. Neurology, 67, 2042–4.
50.Werbrouck, B. F. and de Bleecker, J. L. (2006) Intracerebral haemorrhage in CADASIL. A case report. Acta Neurol Belg, 106, 219–21.
51.Auer, D. P., Putz, B., Gossl, C. et al. (2001) Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology, 218, 443–51.
52.Chabriat, H., Levy, C., Taillia, H. et al. (1998) Patterns of MRI lesions in CADASIL. Neurology, 51, 452–7.
53.Chabriat, H., Mrissa, R., Levy, C. et al. (1999) Brain stem MRI signal abnormalities in CADASIL. Stroke, 30, 457–9.
54.O’Sullivan, M., Jones, D. K., Summers, P. E. et al. (2001) Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline. Neurology, 57, 632–8.
55.van den Boom, R., Lesnik Oberstein, S. A., van Duinen, S. G. et al. (2002) Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology, 224, 791–6.
56.van den Boom, R., Lesnik Oberstein, S. A., Spilt, A. et al. (2003) Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab, 23, 599604.
57.Liem, M.K., Lesnik Oberstein, S.A.J., Haan, J. et al. (2009) Cerebrovascular reactivity is a main determinant of white matter hyperintensity progression in CADASIL. AJNR Am J Neuroradiol, 60, 1244–7.
58.Opherk, C., Peters, N., Holtmannspotter, M. et al. (2006) Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke, 37, 2684–9.
59.Dichgans, M., Filippi, M., Bruning, R. et al. (1999) Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology, 52, 1361–7.
59.Peters, N., Holtmannspotter, M., Opherk, C. et al. (2006) Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology, 66, 1517–22.
60.Davous, P. (1998) CADASIL: a review with proposed diagnostic criteria. Eur J Neurol, 5, 219–33.
61.Markus, H. S., Martin, R. J., Simpson, M. A. et al. (2002) Diagnostic strategies in CADASIL. Neurology, 59, 1134–8.
62.O’Riordan, S., Nor, A. M. and Hutchinson, M. (2002) CADASIL imitating multiple sclerosis: the importance of MRI markers. Mult Scler, 8, 430–2.
63.Trojano, M. and Paolicelli, D. (2001) The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci, 22(Suppl 2), S98–102.
64.Chabriat, H., Pappata, S., Poupon, C. et al. (1999) Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke, 30, 2637–43.
65.Benisty, S., Reyes, S., Godin, O., et al. (2012). White-matter lesions without lacunar infarcts in CADASIL. J Alzheimers Dis, 29, 903911.
66.Lee, JS, Choi, JC, Kang, SY, et al. (2011). J Clin Neurol, 7, 210–14.
67.Trojano, L., Ragno, M., Manca, A. and Caruso, G. (1998) A kindred affected by cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A 2-year neuropsychological follow-up. J Neurol, 245, 217–22.
68.Scheid, R., Preul, C., Lincke, T. et al. (2006) Correlation of cognitive status, MRI- and SPECT-imaging in CADASIL patients. Eur J Neurol, 13, 363–70.
69.Viswanathan, A., Godin, O., Jouvent, E. et al. (2010) Impact of MRI markers in subcortical vascular dementia: A multi-modal analysis in CADASIL. Neurobiol Aging, 31, 1629–36.
70.Jouvent, E., Mangin, J.F., Porcher, R. et al. (2008) Cortical changes in cerebral small vessel diseases: a 3D MRI study of cortical morphology in CADASIL. Brain, 131, 2201–08.
71.Jouvent, E., Mangin, J.F., Duchesnay, E. et al. (2012) Longitudinal changes of cortical morphology in CADASIL. Neurobiol Aging, 33, 1002.e291002.e36.
72.Righart, R., Deuring, M., Gonik, M. et al. (2013). Impact of regional cortical and subcortical changes on processing speed in cerebral small vessel disease. NeuroImage: Clinical, 2, 854–61.
73.Duering, M., Gonik, M., Zieren, N. et al. (2012). Identification of a strategic brain network underlying processing speed deficits in vascular cognitive impairment. NeuroImage, 66, 177183.
74.Duering, M., Zieren, N., Herve, D. et al. (2011). Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain, 134, 2366–75.
75.Filippi, M. and Grossman, R. I. (2002) MRI techniques to monitor MS evolution: the present and the future. Neurology, 58, 1147–53.
76.Moseley, M. (2002) Diffusion tensor imaging and aging: a review. NMR Biomed, 15, 553–60.
77.Malloy, P., Correia, S., Stebbins, G. and Laidlaw, D. H. (2007) Neuroimaging of white matter in aging and dementia. Clin Neuropsychol, 21, 73109.
78.O’Sullivan, M., Morris, R. G., Huckstep, B. et al. (2004) Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry, 75, 441–7.
79.Molko, N., Pappata, S., Mangin, J. F. et al. (2001) Diffusion tensor imaging study of subcortical gray matter in CADASIL. Stroke, 32, 2049–54.
80.O’Sullivan, M., Barrick, T. R., Morris, R. G., Clark, C. A. and Markus, H. S. (2005) Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology, 65, 1584–90.
81.Molko, N., Cohen, L., Mangin, J. F. et al. (2002) Visualizing the neural bases of a disconnection syndrome with diffusion tensor imaging. J Cogn Neurosci, 14, 629–36.
82.Holtmannspotter, M., Peters, N., Opherk, C. et al. (2005) Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke, 36, 2559–65.
83.Correia, S., Lee, S. Y., Voorn, T. et al. (2008) Quantitative tractography metrics of white matter integrity in diffusion-tensor MRI. Neuroimage, 42, 568–81.
84.Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E. and Bousser, MG. (1993) Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke, 24, 122–5.
85.Jung, H. H., Bassetti, C., Tournier-Lasserve, E. et al. (1995) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a clinicopathological and genetic study of a Swiss family. J Neurol Neurosurg Psychiatry59, 138–14.
86.Liem, M.K., van der Grond, J., Versluis, M.J. et al. (2010) Lenticulostriate arterial lumina are normal in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a high-field in vivo MRI study. Stroke, 41, 2812–16.
87.Ruchoux, M. M. and Maurage, C. A. (1998) Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol, 24, 60–5.
88.Brulin, P., Godfraind, C., Leteurtre, E. and Ruchoux, M. M. (2002) Morphometric analysis of ultrastructural vascular changes in CADASIL: analysis of 50 skin biopsy specimens and pathogenic implications. Acta Neuropathol (Berl), 104, 241–8.
89.Dziewulska, D. and Lewandowska, E. (2012) Pericytes as a new target for pathological processes in CADASIL. Neuropathology, 32, 515–21.
90.Okeda, R., Arima, K. and Kawai, M. (2002) Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke, 33, 2565–9.
91.Brennan-Krohn, T., Salloway, S., Correia, S. et al. (2010) Glial vascular degeneration in CADASIL. J Alzheimers Dis, 21, 1392–402.
92.Prakash, N., Hansson, E., Betsholtz, C., Mitsiadis, T. and Lendahl, U. (2002) Mouse Notch 3 expression in the pre- and postnatal brain: relationship to the stroke and dementia syndrome CADASIL. Exp Cell Res, 278, 3144.
93.Lundkvist, J., Zhu, S., Hansson, E. M. et al. (2005) Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis, 41, 1322.
94.Ruchoux, M. M., Domenga, V., Brulin, P. et al. (2003) Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol, 162, 329–42.
95.Dubroca, C., Lacombe, P., Domenga, V. et al. (2005) Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke, 36, 113–17.
96.Lacombe, P., Oligo, C., Domenga, V., Tournier-Lasserve, E. and Joutel, A. (2005) Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke, 36, 1053–8.
97.Carmelli, D., Decarli, C., Swan, G. E. et al. (1998) Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke, 29, 1177–81.
98.Atwood, L. D., Wolf, P. A., Heard-Costa, N. L. et al. (2004) Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke, 35, 1609–13.
99.Turner, S. T., Jack, C. R., Fornage, M. et al. (2004) Heritability of leukoaraiosis in hypertensive sibships. Hypertension, 43, 483–7.
100.Leblanc, G. G., Meschia, J. F., Stuss, D. T. and Hachinski, V. (2006) Genetics of vascular cognitive impairment: the opportunity and the challenges. Stroke, 37, 248–55.
101.Sierra, C., de la Sierra, A., Mercader, J. et al. (2002) Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens, 20, 519–24.
102.Schmidt, R., Schmidt, H., Fazekas, F. et al. (2000) MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: three-year follow-up of the Austrian stroke prevention study. Arterioscler Thromb Vasc Biol, 20, 1811–16.
103.Skoog, I. (1997) The relationship between blood pressure and dementia: a review. Biomed Pharmacother, 51, 367–75.
104.Bronge, L., Fernaeus, S., Blomberg, M. et al. (1999) White matter lesions in Alzheimer patients are influenced by apoliprotein E genotype. Dement Geriatr Cogn Disord, 10, 8996.
105.Barber, R., Gholkar, A., Scheltens, P. et al. (1999) Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol, 56, 961–5.
106.Sawada, H., Udaka, F., Izumi, Y. et al. (2000) Cerebral white matter lesions are not associated with ApoE genotype but with age and female sex in Alzheimer’s disease. J Neurol Neurosurg Psychiatry, 68, 653–6.
107.De Leeuw, F. E., Richard, F., de Groot, J. C. et al. (2004) Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke, 35, 1057–60.
108.Shawber, C. J. and Kitajewski, J. (2004) Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays, 26, 225–34.
109.Mazzei, R., Conforti, F. L., Lanza, P. L. et al. (2004) A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL. Neurology, 63, 561–4.
110.Weinmaster, G. (1997) The ins and outs of Notch signaling. Mol Cell Neurosci, 9, 91102.
111.Baron, M. (2003) An overview of the Notch signalling pathway. Semin Cell Dev Biol, 14, 113–19.
112.Bianchi, S., Dotti, M. T. and Federico, A. (2006) Physiology and pathology of the Notch signalling system. J Cell Physiol, 207, 300–8.
113.Joutel, A., Andreux, F., Gaulis, S. et al. (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest, 105, 597605.
114.Louvi, A., Arboleda-Velasquez, J. F. and Artavanis-Tsakonas, S. (2006) CADASIL: a critical look at a Notch disease. Dev Neurosci, 28, 512.
115.Arboleda-Velasquez, J. F., Lopera, F., Lopez, E. et al. (2002) C455R Notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology, 59, 277–9.
116.Donahue, C. P. and Kosik, K. S. (2004) Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL. Genomics, 83, 5965.
117.Arboleda-Velasquez, J. F., Rampal, R., Fung, E. et al. (2005) CADASIL mutations impair Notch3 glycosylation by Fringe. Hum Mol Genet, 14, 1631–9.
118.Karlström, H., Beatus, P., Dannaeus, K. et al. (2002) A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc Natl Acad Sci USA, 99, 17119–24.
119.Haritunians, T., Boulter, J., Hicks, C. et al. (2002) CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand. Circ Res, 90, 506–8.
120.Haritunians, T., Chow, T., De Lange, R. P. et al. (2005) Functional analysis of a recurrent missense mutation in Notch3 in CADASIL. J Neurol Neurosurg Psychiatry, 76, 1242–8.
121.Dichgans, M., Ludwig, H., Muller-Hocker, J., Messerschmidt, A. and Gasser, T. (2000) Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet, 8, 280–5.
122.Joutel, A., Monet, M., Domenga, V., Riant, F. and TournierLasserve, E. (2004) Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling pathway. Am J Hum Genet, 74, 338–47.
123.Monet-Lepretre, M., Haddad, I., Baron-Menguy, C. et al. (2013) Abnormal recruitment of extracellular matrix proteins by excess Notch3: a new pathomechanism in CADASIL. Brain, 136, 1830–45.
124.Carrera, P., Stenirri, S., Ferrari, M. and Battistini, S. (2001) Familial hemiplegic migraine: a ion channel disorder. Brain Res Bull, 56, 239–41.
125.Koga, S. J., Hodges, M., Markin, C. and Gorman, P. (1995) MELAS syndrome. West J Med, 163, 379–81.
126.Pescini, F., Nannucci, S., Bertaccini, B. et al. (2012) The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) Scale: A screening tool to select patients for NOTCH3 gene analysis. Stroke, 43, 2871–76.
127.Malandrini, A., Mykkanen, K., Ruchoux, M.M. et al. (2007) Diagnostic value of ultrastructural skin biopsy studies in CADASIL. Neurology, 24, 1430.
128.Tikka, S., Mykkänen, K., Ruchoux, M.M. et al. (2009) Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain, 132, 933–9.
129.Lewandowska, E., Szpak, G.M., Wierzba-Bobrowicz, T. et al. (2010) Capillary vessel wall in CADASIL angiopathy. Folia Neuropathol, 48, 104–15.
130.Peters, N., Freilinger, T., Opherk, C., Pfefferkorn, T. and Dichgans, M. (2007) Effects of short-term atorvastatin treatment on cerebral hemodynamics in CADASIL. J Neurol Sci, 260, 100–5.
131.Willmot, M., Gray, L., Gibson, C., Murphy, S. and Bath, P. M. (2005) A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide, 12, 141–9.
132.Schulman, S. P., Becker, L. C., Kass, D. A. et al. (2006) l-arginine therapy in acute myocardial infarction: the Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA, 295, 5864.
133.Donnini, I., Nannucci, S., Valenti, R. et al. (2012) Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. J Headache Pain, 13, 299302.